Longo DL - Search Results

1

Alterations in T cell receptor and signal transduction molecules in melanoma patients.

Zea AH, Curti BD, Longo DL, Alvord WG, Strobl SL, Mizoguchi H, Creekmore SP, O'Shea JJ, Powers GC, Urba WJ, et al. Zea AH, et al. Among authors: longo dl. Clin Cancer Res. 1995 Nov;1(11):1327-35. Clin Cancer Res. 1995. PMID: 9815928

2

Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice.

Franco JL, Ghosh P, Wiltrout RH, Carter CR, Zea AH, Momozaki N, Ochoa AC, Longo DL, Sayers TJ, Komschlies KL. Franco JL, et al. Among authors: longo dl. Cancer Res. 1995 Sep 1;55(17):3840-6. Cancer Res. 1995. PMID: 7641202

3

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, et al. Finke JH, et al. Among authors: longo dl. Cancer Res. 1993 Dec 1;53(23):5613-6. Cancer Res. 1993. PMID: 8242613

4

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment.

Curti BD, Urba WJ, Alvord WG, Janik JE, Smith JW 2nd, Madara K, Longo DL. Curti BD, et al. Among authors: longo dl. Cancer Res. 1993 May 15;53(10 Suppl):2204-7. Cancer Res. 1993. PMID: 8485703 Clinical Trial.

5

Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

Zea AH, Ochoa MT, Ghosh P, Longo DL, Alvord WG, Valderrama L, Falabella R, Harvey LK, Saravia N, Moreno LH, Ochoa AC. Zea AH, et al. Among authors: longo dl. Infect Immun. 1998 Feb;66(2):499-504. doi: 10.1128/IAI.66.2.499-504.1998. Infect Immun. 1998. PMID: 9453602 Free PMC article.

6

Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer.

Kopp WC, Urba WJ, Rager HC, Alvord WG, Oppenheim JJ, Smith JW 2nd, Longo DL. Kopp WC, et al. Among authors: longo dl. Clin Cancer Res. 1996 Mar;2(3):501-6. Clin Cancer Res. 1996. PMID: 9816196 Clinical Trial.

7

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.

Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. Mizoguchi H, et al. Among authors: longo dl. Science. 1992 Dec 11;258(5089):1795-8. doi: 10.1126/science.1465616. Science. 1992. PMID: 1465616

8

Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.

Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ, Longo DL. Sing GK, et al. Among authors: longo dl. Cell Growth Differ. 1990 Nov;1(11):549-57. Cell Growth Differ. 1990. PMID: 1965139

9

Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.

Urba WJ, Steis RG, Longo DL, Kopp WC, Maluish AE, Marcon L, Nelson DL, Stevenson HC, Clark JW. Urba WJ, et al. Among authors: longo dl. Cancer Res. 1990 Jan 1;50(1):185-92. Cancer Res. 1990. PMID: 2293554

10

Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.

Martin A, Nerenstone S, Urba WJ, Longo DL, Lawrence JB, Clark JW, Hawkins MJ, Creekmore SP, Smith JW 2nd, Steis RG. Martin A, et al. Among authors: longo dl. J Clin Oncol. 1990 Apr;8(4):721-30. doi: 10.1200/JCO.1990.8.4.721. J Clin Oncol. 1990. PMID: 2313337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters